Decreased high-molecular-weight adiponectin in gestational diabetes: Implications for the pathophysiology of Type 2 diabetes

Diabetic Medicine

Volumn 24, Issue 3, 2007, Pages 245-252

  Retnakaran, R ^a,b,e   Connelly, P W ^c,d   Maguire, G ^d   Sermer, M ^b   Zinman, B ^a,b   Hanley, A J G ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Pediatric Oral and Maxillofacial Surgery   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Adiponectin; Gestational diabetes; High molecular weight adiponectin; Pregnancy; Type 2 diabetes

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COVARIANCE; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; MOLECULAR WEIGHT; MULTIPLE LINEAR REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PREGNANCY DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; PROVOCATION TEST; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; THIRD TRIMESTER PREGNANCY;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, THIRD; RISK FACTORS;

EID: 33846993043     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02077.x     Document Type: Article

References (27)

1. Goldstein BJ, Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004; 89: 2563-2568.
2. Cnop C, Havel PJ, Utzschneider K, Carr D, Sinha M, Boyko E et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003; 46: 459-469.
3. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsudu M, Okamoto Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599.
4. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni P et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002; 360: 57-58.
5. Spranger J, Kroke A, Mohlig M. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003; 361: 226-228.
6. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H et al., Funagata Study. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study. Diabetes Care 2003; 26: 2015-2020.
7. Snehalatha C, Mukesh B, Simon M, Vishwanathan V, Haffner SM, Ramachandran A. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 2003; 26: 3226-3229.
8. Tsao TS, Tomas E, Murrey H, Hug C, Lee D, Ruderman N et al. Role of disulfide bonds in Acrp30/adiponectin structure and signalling specificity: different oligomers activate different signal transduction pathways. J Biol Chem 2003; 278: 50810-50817.
9. Peake PW, Kriketos A, Campbell L, Shen Y, Charlesworth JA. The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals. Eur J Endocrinol 2005; 153: 409-417.
10. Pajvani UB, Hawkins M, Combs T, Rajala M, Doebber T, Berger J et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004; 279: 12152-12162.
11. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004; 94: e27-e31.
12. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006; 55: 249-259.
13. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005; 115: 485-491.
14. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 2004; 27: 799-800.
15. Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, Drevon C. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand 2004; 83: 341-347.
16. Williams MA, Qiu C, Muy-Rivera M, Vadachkoria S, Song T, Luthy DA. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 2004; 89: 2306-2311.
17. Worda C, Leipold H, Gruber C, Kautzky-Willer A, Knofler M, Bancher-Todesca D. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. Am J Obstet Gynecol 2004; 191: 2120-2124.
18. Retnakaran R, Hanley AJ, Raif N, Hirning CR, Connelly PW, Sermer M et al. Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia 2005; 48: 993-1001.
19. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 2003; 88: 3507-3512.
20. Retnakaran R, Hanley AJ, Connelly PW, Maguire G, Sermer M, Zinman B. Low serum levels of high molecular weight adiponectin in Indo-Asian women during pregnancy: evidence of ethnic variation in adiponectin isoform distribution. Diabetes Care 2006; 29: 1377-1379.
21. Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470.
22. Kirwan JP, Huston-Presley L, Kalhan SC, Catalano PM. Clinically useful estimates of insulin sensitivity during pregnancy: validation studies in women with normal glucose tolerance and gestational diabetes mellitus. Diabetes Care 2001; 24: 1602-1607.
23. Polonsky KS, Rubenstein AH. C-peptide as a measure of the secretion and hepatic extraction of insulin. Diabetes 1984; 33: 486-494.
24. Stumvoll M, Van Haeften TV, Fritsche A, Gerich J. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 2001; 24: 796-797.
25. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Gioco J et al. Preservation of pancreatic B-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002; 51: 2796-2803.
26. Bobbert T, Rochlitz H, Wegewitz U, Akpulat S, Mai K, Weickert M et al. Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 2005; 54: 2712-2719.
27. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al., Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.